Source: ERJ Open Res, 4 (1) 00074-2017; 10.1183/23120541.00074-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Khalide Azam, Nureisha Cadir, Carla Madeira, Stephen H. Gillespie, Wilber Sabiiti. OMNIgene.SPUTUM suppresses contaminants while maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport. ERJ Open Res, 4 (1) 00074-2017; 10.1183/23120541.00074-2017

Member's Comments

No comment yet.

Related content which might interest you: Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture Source: Eur Respir J 2007; 30: 501-507 Year: 2007 Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Quantification of long term uptake and metabolism of isoniazid in patients treated for Mycobacterium tuberculosis infection Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination Source: Eur Respir J 2015; 45: 289-291 Year: 2015 The effects of drug resistance phenotype on proliferation of Mycobacterium tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004 Rapid resistance detection of Mycobacterium tuberculosis to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system. Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001 No human transmission of Mycobacterium malmoense in a perfect storm setting Source: Eur Respir J 2012; 40: 1576-1578 Year: 2012 Standardization and quality control to determine the drug resistance of M. tuberculosis in Kazakhstan Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Source: Eur Respir J 2010; 35: 692-694 Year: 2010 Accelerated analysis of reactivation of the dormant Mycobacterium tuberculosis using mycobacteriophage D29. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Influence of glutoxim and its derivatives on the growth of mycobacterium tuberculosis (Mtb) Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 The main causes which are responsible for secondary chemoresistance of Mycobacterium tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis: contribution of murine studies Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020 Year: 2021 On the nature of Mycobacterium tuberculosis-latent bacilli Source: Eur Respir J 2004; 24: 1044-1051 Year: 2004